Why a biopsychosocial approach is needed when studying the sexual effects of contraception by Elaut, Els
Why a biopsychosocial approach is very much needed in studying sexual 1 
effects of contraception 2 
Running head: Sexual motivation and contraception 3 
 4 
Els Elaut 5 
Center for Sexology and Gender, University Hospital Ghent 6 
De Pintelaan 185, Ghent, Belgium 7 
003293322159, els.elaut@ugent.be 8 
  9 
The FDA-approval of the first oral contraceptive on May 9th 1960 stirred the public and scientific 10 
debate. Initially, concerns regarding sexual effects in women were limited. After decades of large-11 
scale use of oral contraception (OC) in over 100 million women worldwide, it is amazing how little we 12 
know about the effects on women’s sexuality. In the late 1980s, the Human Reproduction Program of 13 
the WHO appointed John Bancroft to conduct a series of studies into OC and sexual health(1-4). The 14 
author will discuss three main conclusions of this series, supplemented with recent additions in the 15 
field, to show why a biopsychosocial approach in this area is urgently needed.  16 
To be able to put studies on OC use and female sexual desire (or ‘sexual interest’ or ‘sexual 17 
motivation’) in a correct perspective, the author wishes to refer to a leading theoretical, 18 
biopsychosocial model called the incentive motivation model (5) (Figure 1). It is stated that sexual 19 
desire or sexual motivation (in both women and men!) is the result of a complex and layered process. 20 
They consider that sexual motivation typically emerges when a functional ‘sexual system’ (influenced 21 
by receptors, sex steroids, genetic sensitivity etcetera) is activated by an internal or external stimulus 22 
that is sexually meaningful to the individual concerned. This stimulus can be visual, olfactory or 23 
otherwise, and its valence depends on the sexual memory (attitudes, norms and previous sexual 24 
experiences) of the person (Figure 1). For example, some individuals will find a certain smell or sound 25 
sexually stimulating since it reminds them of earlier positive experiences with that smell or sound, in 26 
their personal memory associated with a sexual reward. This same stimulus can be experienced as 27 
neutral or even negative by another person, depending on the specific associations in that persons 28 
sexual memory (5). 29 
 30 
1. OC use can result in lower sexual motivation, although not in all users 31 
Returning to the WHO-studies above, firstly, they point towards a reduction in sexual desire (or 32 
sexual motivation), at least in some OC starters(3;4). A systematic review has found around 15% of OC 33 
users to experience negative effects on sexual desire(6), although it remains unclear as to how this 34 
group differs from women who experience no or a positive change in sexual desire. Since the first 35 
studies, the iatrogenic hypo-androgenism hypothesis has been put forward frequently; this 36 
hypothesis states that the OC-induced decrease in free testosterone (FT) could be responsible for 37 
sexual side effects. Until today, no methodologically sound study could find a causal link between 38 
this FT decrease and lower sexual motivation. One large prospective study in pill starters found a 39 
relation between the extent of diminished FT and the frequency of sexual thoughts after three 40 
months of OC use. Most women, however, did not experience a decreased sexual motivation, 41 
despite a substantial decrease in FT (7).  42 
Based on these and other observations, John Bancroft proposed his desensitization hypothesis: 43 
women are not only sensitive to lower androgen levels than men, they also show greater inter-44 
individual behavioral variations in their response to FT (8). So, more genetic variability (e.g. in 45 
androgen receptor sensitivity) could become evident at lower FT levels and would be manifested as a 46 
greater variability in behavioral responsiveness. One Canadian study found partial confirmation in 47 
their observation that women with a more ‘masculine’ 2D:4D ratio (second digit: fourth digit, an 48 
anthropometrical indicator of androgen exposure) are more at risk for OC side effects. Women with a 49 
lower 2D:4D ratio (usually seen in men) more often report a history of emotional and sexual side 50 
effects with OC use (9). A more recent study found that sexual motivation in users of hormonal 51 
contraception is related to genetic sensitivity (measured as a variation of the androgen receptor gene 52 
on the X-chromosome). Further, women also indicated to experience a stronger motivation while 53 
using the vaginal ring, when their partner also reported stronger sexual motivation for them, and in 54 
the absence of negative mood (10). These results confirm the incentive motivation model: both 55 
genetic factors (influencing the sexual arousability or sensitivity of the sexual system, left in Figure 1), 56 
as context (sexual motivation partner) and individual factors (mood) (both right in Figure 1), 57 
determine the sexual motivation of users of hormonal contraception. Based on these findings, one 58 
could advocate a prospective biopsychosocial approach in studying sexual effects of OC, or more 59 
broadly, hormonal contraception. 60 
 61 
2. Sexual and emotional side effects are the most important reasons to discontinue OCs 62 
Second, sexual side effects not only exist, sexual and emotional side effects are the most important 63 
reasons to discontinue OCs. While prospective studies exist on the reasons for discontinuing OCs, 64 
they often only mention self-reported side effects (11) or do not include sexual variables. To the 65 
author’s knowledge, only one study assesses the self-reported side effects in a group of pill starters 66 
(women who had never used OC), while also prospectively and repeatedly (for 12 months) assessing 67 
physical and emotional well-being, perimenstrual symptoms, sexual interest, enjoyment and 68 
frequency of sexual activity (2). In this group, 47% discontinued and 14% switched to another OC. The 69 
authors note that only 8% of women specifically report sexual side effects as a reason to discontinue 70 
OC use. However, a logistic regression (explaining 87% of the variance in outcome) on these data 71 
show emotional (worsening of PMS) and sexual side effects (decreased frequency of sexual thoughts 72 
and diminished sexual arousability) to be the best predictors of OC discontinuation(2). This very 73 
different result between the self-report and the regression model should make us consider: why do 74 
women hesitate to report sexual side effects as reasons for discontinuation, while they are shown to 75 
be highly relevant and predictive of (dis)continuation? Possibly, an absence of information on 76 
potential sexual side effects during contraception counseling, as well as the general societal taboo on 77 
talking about sex could be hindering women’s self-report . Clearly, providers should ‘model’ an 78 
attitude of talking about sex and sexual side effects, not only when providing a first OC prescription, 79 
but also when inquiring for possible side effects afterwards.  80 
 81 
3. Sexual motivation might get ‘flattened out’ during the contraceptive cycle 82 
Finally, the pattern of sexual motivation in OC users might differ from that of women not using 83 
hormonal contraception. Cycling women experience a peak in sexual motivation around mid-84 
cycle(12,13). One retrospective study in a large sample of 4112 women (non-pill users, N=3252, and pill 85 
users, N=860) brought to light a pattern with less peaks and troughs in sexual motivation during pill-86 
driven cycles, compared to women in non-pill, menstrual cycles (1). A more recent, prospective study 87 
looked at the cyclical patterns of sexual desire and the frequency of sexual activity in OC users(14). Its 88 
findings confirm those of earlier retrospective research: no mid-cycle peak is seen, leading to the 89 
conclusion that sexual motivation might indeed be ‘flattened out’ during pill-driven cycles. A more 90 
positive affect in the women is related to stronger sexual motivation, both pertaining to the interest 91 
in solitary sexual behavior (masturbation) as the interest in partnered sexual behavior.  92 
 93 
Conclusion 94 
Although genetic factors appear to have relevance, research on the sexual motivation in 95 
contraception users should look further than the biological ‘arousability’ of the sexual system by 96 
measuring only testosterone levels. Feeling desired by a partner and experiencing a positive affect 97 
clearly are psychosocial conditions making it possible for stimuli to activate the sexual system, and 98 
sexual motivation to emerge. When it comes to studying contraception and female sexuality, the 99 
interaction between genetics, hormones, mood, relationship and personality is paramount. 100 
Biopsychosocial models such as the incentive motivation theory could help researchers in broadening 101 
our understanding of this field. 102 
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Figure 1. Non-exhaustive overview of factors influencing activation of sexual motivation. Based on 159 
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